Bellevue Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.68M | Sell |
38,400
-1,600
| -4% | -$112K | 0.06% | 90 |
|
|
2025
Q1 | $2.94M | Buy |
40,000
+4,300
| +12% | +$316K | 0.07% | 97 |
|
|
2024
Q4 | $2.34M | Buy |
35,700
+2,200
| +7% | +$144K | 0.05% | 106 |
|
|
2024
Q3 | $2.61M | Sell |
33,500
-8,700
| -21% | -$678K | 0.04% | 103 |
|
|
2024
Q2 | $3.29M | Buy |
42,200
+19,000
| +82% | +$1.48M | 0.05% | 101 |
|
|
2024
Q1 | $1.57M | Sell |
23,200
-28,400
| -55% | -$1.92M | 0.02% | 112 |
|
|
2023
Q4 | $3.48M | Sell |
51,600
-33,000
| -39% | -$2.22M | 0.05% | 102 |
|
|
2023
Q3 | $5.73M | Sell |
84,600
-1,000
| -1% | -$67.7K | 0.09% | 99 |
|
|
2023
Q2 | $6.13M | Buy |
85,600
+14,000
| +20% | +$1M | 0.09% | 98 |
|
|
2023
Q1 | $4.97M | Buy |
71,600
+3,100
| +5% | +$215K | 0.07% | 104 |
|
|
2022
Q4 | $4.65M | Buy |
68,500
+24,100
| +54% | +$1.64M | 0.06% | 111 |
|
|
2022
Q3 | $2.46M | Sell |
44,400
-42,600
| -49% | -$2.36M | 0.04% | 119 |
|
|
2022
Q2 | $5.75M | Sell |
87,000
-2,600
| -3% | -$172K | 0.08% | 111 |
|
|
2022
Q1 | $5.94M | Buy |
89,600
+30,600
| +52% | +$2.03M | 0.07% | 113 |
|
|
2021
Q4 | $3.44M | Buy |
+59,000
| New | +$3.44M | 0.04% | 134 |
|